Piet Portegijs

Affiliations

Department of Family Medicine, School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands.

Publications (1)

Ribociclib with an Aromatase Inhibitor for Previously Untreated, HR-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

PharmacoEconomics

Avec: Nasuh C Büyükkaramikli , Saskia de Groot , Rob Riemsma , Debra Fayter , Nigel Armstrong , Piet Portegijs , Steven Duffy , Jos Kleijnen , Maiwenn J Al

Réseau de co-auteurs

Nasuh C Büyükkaramikli 1 collaboration

Saskia de Groot 1 collaboration

Rob Riemsma 1 collaboration

Debra Fayter 1 collaboration

Nigel Armstrong 1 collaboration

Steven Duffy 1 collaboration

Jos Kleijnen 1 collaboration

Maiwenn J Al 1 collaboration